September 21, 2010 – A new drug-eluting stent system has received CE mark approval for diabetic patients and those experiencing a heart attack. The PROMUS element everolimus-eluting stent system, made by Boston Scientific, can be used in patients with concomitant diabetes mellitus as well as those suffering from an acute myocardial infarction (AMI).

September 21, 2010 – Two companies announced that they have entered into a distribution agreement in the United States. The agreement allows Vascular Solutions to distribute Shepherd Scientific’s Angio Assist and Teirstein Edge products.

September 21, 2010 – Ventricular assist devices (VADs) can restore normal hemodynamics and support recovery of native cardiac function after acute myocardial infarction (AMI), according to a study published in the September 2010 issue of The Annals of Thoracic Surgery. The study looked at patients who used Abiomed’s AB5000 Ventricular Assist Device.

September 20, 2010 - A phase 1 porcine model study demonstrated that it is possible to successfully and repeatedly deliver a mitral valve implant.

September 20, 2010 – Transcatheter ventricular assist device (VAD) company Abiomed will highlight its devices at several events during the 2010 Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, Sept, 21-25, at the Washington Convention Center in Washington, D.C.

September 20, 2010 - A new intravascular ultrasound (IVUS) coronary imaging system integrating plaque spectroscopy to better guide therapy will be highlighted during the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting.

September 17, 2010 - An aortic valve has been successfully implanted in the acute porcine model by Transcatheter Technologies GmbH (TT) using its Trinity system. The acute in vivo study of the system has shown: • Accurate stepwise positioning of Trinity via an antegrade transapical approach.